UK agency backs cancer drug after Sanofi cuts price

LONDON, April 22 (Reuters) - Britain's healthcare cost

watchdog NICE said on Friday it had changed its mind and decided

to recommend Sanofi's prostate cancer drug Jevtana

after the French company agreed to a further discount.

Read more